Professor of Infection Pharmacology
Institute of Infection and Global Health, University of Liverpool
Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital
Gerry is Professor of Infection Pharmacology and Honorary Consultant in Infectious Diseases at the University of Liverpool. He qualified in Medicine at the University of Southampton Medical School in 1991. He ran the TB programme at Hlabisa hospital, Kwazulu/Natal, South Africa from 1994-1998, later obtaining an MSc in Epidemiology from the London School of Hygiene and a PhD in Pharmacology from the University of Liverpool. From 2007-2009, he was based at the Mahidol-Oxford Research Unit in Bangkok where he worked on clinical PK-PD studies of anti-tuberculosis and influenza therapy and subsequently as theme leader in HIV-TB pharmacology at the Malawi-Liverpool-Wellcome Unit in Blantyre, Malawi (2012-2014). He is an editor for the Cochrane Infectious Diseases Group, specialising in tuberculosis and has extensive experience of Phase II and III clinical trials in tuberculosis in differing roles. He was the academic co-ordinator of PreDiCT-TB, an Innovative Medicines Initiative supported consortium addressing preclinical development of combination regimens for tuberculosis and since 2012 has participated in the WHO Taskforces for the development of new policies for the treatment of tuberculosis and pharmacokinetics and pharmacodynamics of tuberculosis drugs.
Gerry is a member of LIV-TB, the cross-campus tuberculosis research interest group and a longstanding lecturer on the DTM&H tuberculosis and fever modules.